Skip to main content
[Preprint]. 2023 Oct 6:rs.3.rs-3370395. [Version 1] doi: 10.21203/rs.3.rs-3370395/v1

Table 2.

Schedule of events

Visits Baseline Day 1 Baseline Day 2 Month 31 +/− 21 days Month 62 +/− 21 Days Month 12 +/− 21 Days
Informed Consent X
Demographic Information X
Medical and Surgical History X
Inclusion Exclusion X
Vital Signs X X X X X
Physical Exam X3 X3 X X X
Pregnancy Test4 X X X X
10 Meter Walk X
100 Meter Timed X X X X X
NSAD X X X X X
4 Stair Climb X X X X X
Timed Up and Go (TUG) X X X X X
Handheld Dynamometry X X X X X
Performance Upper Limb PUL 2.0 X X X X X
9 Hole Peg Test X X X X X
Spirometry X X X X X
Concomitant Meds X X X X X
Domain Delta Questionnaire X X X X
Patient Reported Outcome Measures X3 X3 X X X
Urine Biomarkers X X X
Blood Biomarkers X X X X
Prior muscle biopsy acquired (if performed) X
Review adverse events X X X X
1

For individuals with SGCA-G pathogenic variants

2

n/a to DNAJB6/ LGMDD1cohort

3

Assessment can occur on baseline day 1 or baseline day 2.

4

Pregnancy test for women of childbearing potential